Arixtra (Fondaparinux sodium injection), Organon/Sanofi-Synthelabo
New biologic: Factor Xa inhibitor for reducing risk of blood clotsafter orthopedic surgeries
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
